abstract details

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

Disease Modifying Anti-Rheumatic Drugs (DMARD)


Onecia Benjamin 1, Pankaj Bansal 2, Amandeep Goyal 3, Sarah L. Lappin 4

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.

2020 Jul 4.

Author Information

1 SUNY Upstate

2 Mayo Clinic Health System

3 Marietta Memorial Hospital

4 Upstate University Hospital

Free Books & Documents


Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs indicated for the treatment of inflammatory arthritides including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). They can also be used to in the treatment of other disorders including connective tissue disease such as systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and Sjogren syndrome (SS), as well as in treatment of inflammatory myositis, vasculitis, uveitis, inflammatory bowel disease, and some types of cancers.